Tamoxifen for early breast cancer: an overview of the randomised trials

@article{Group1998TamoxifenFE,
  title={Tamoxifen for early breast cancer: an overview of the randomised trials},
  author={Early Breast Cancer Trialists' Collaborative Group},
  journal={The Lancet},
  year={1998},
  volume={351},
  pages={1451-1467}
}
BACKGROUND There have been many randomised trials of adjuvant tamoxifen among women with early breast cancer, and an updated overview of their results is presented. METHODS In 1995, information was sought on each woman in any randomised trial that began before 1990 of adjuvant tamoxifen versus no tamoxifen before recurrence. Information was obtained and analysed centrally on each of 37000 women in 55 such trials, comprising about 87% of the worldwide evidence. Compared with the previous such… CONTINUE READING
947 Citations

Paper Mentions

INTERVENTIONAL CLINICAL TRIAL
Phase II trial of 2 years of standard adjuvant endocrine therapy after low risk hormone receptor positive, HER2 negative, node negative breast cancer in women older than 50 at… Expand
ConditionsBreast Cancer Female, Hormone Receptor Positive Tumor
InterventionDrug
INTERVENTIONAL CLINICAL TRIAL
The primary objective of this 2-year pilot project is to test the hypothesis that skeletal response to aromatase inhibitors is determined by polymorphisms of the CYP19 gene.  
ConditionsBreast Cancer, Postmenopausal
InterventionBehavioral, Procedure
Tamoxifen – An Update on Current Data and Where it Can Now be Used
  • L. Wickerham
  • Medicine
  • Breast Cancer Research and Treatment
  • 2004
  • 39
Adjuvant aromatase inhibitors
  • 7
Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings.
  • J. Ingle
  • Medicine
  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2005
  • 36
  • PDF
Adjuvant Endocrine Therapy for Postmenopausal Women with Early Breast Cancer
  • J. Ingle
  • Medicine
  • Clinical Cancer Research
  • 2006
  • 14
  • PDF
Exemestane in early breast cancer: a review
  • 12
  • PDF